An evolutionary shift in the regulation of the Hippo pathway between mice and flies

Oncogene

Volumn 33, Issue 10, 2014, Pages 1218-1228

  Bossuyt, W ^a,b,c   Chen, C L ^c   Chen, Q ^d   Sudol, M ^e   Mcneill, H ^f   Pan, D ^d   Kopp, A ^g   Halder, G ^a,b,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF TEXAS   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WEIS CENTER FOR RESEARCH   (United States)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiomotin; Dachs; evolution; Fat; Hippo signaling; Yap

Indexed keywords

ADAPTOR PROTEIN; CADHERIN; CELL ADHESION MOLECULE; CELL MEMBRANE PROTEIN; PDZ PROTEIN;

ADULT; ANIMAL TISSUE; ARTHROPOD; ARTICLE; CELL JUNCTION; CONTROLLED STUDY; DROSOPHILA; EVOLUTIONARY DEVELOPMENTAL BIOLOGY; EVOLUTIONARY RATE; HIPPO PATHWAY; LIVER; MALE; MOUSE; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALIA; ARTHROPODA; ECHINOIDA; MURINAE; MUS; VERTEBRATA;

ANIMALS; CADHERINS; CELL ADHESION MOLECULES; CELL POLARITY; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EVOLUTION, MOLECULAR; FEEDBACK, PHYSIOLOGICAL; GENES, TUMOR SUPPRESSOR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LARVA; LIVER; MALE; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; PHENOTYPE; PHYLOGENY; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 84895929894     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.82     Document Type: Article

References (104)

1. Pan D. The hippo signaling pathway in Development and cancer. Dev Cell 2010; 19: 491-505
2. Halder G, Johnson RL. Hippo signaling: Growth control and beyond. Development 2011; 138: 9-22
3. Zhao B, Li L, Lei Q, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: An updated version. Genes Dev 2010; 24: 862-874
4. Genevet A, Tapon N. The Hippo pathway and apico-basal cell polarity. Biochem J 2011; 436: 213-224
5. Sebe-Pedros A, Zheng Y, Ia Ruiz-Trillo, Pan D. Premetazoan origin of the hippo signaling pathway. Cell Reports 2012; 1: 13-20
6. Hilman D, Gat U. The evolutionary history of YAP and the Hippo/YAP pathway. Mol Biol Evol 2011; 28: 2403-2417
7. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 2010; 107: 8248-8253
8. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 2010; 107: 1431-1436
9. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009; 16: 425-438
10. Oh S, Lee D, Kim T, Kim TS, Oh HJ, Hwang CY et al. Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol Cell Biol 2009; 29: 6309-6320
11. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 2010; 107: 1437-1442
12. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011; 332: 458-461
13. Gaffney CJ, Oka T, Mazack V, Hilman D, Gat U, Muramatsu T et al. Identification, basic characterization and evolutionary analysis of differentially spliced mRNA isoforms of human YAP1 gene. Gene 2012; 509: 215-222
14. Muramatsu T, Imoto I, Matsui T, Kozaki K, Haruki S, Sudol M et al. YAP is a candidate oncogene for esophageal squamous cell carcinoma. Carcinogenesis 2011; 32: 389-398
15. Webb C, Upadhyay A, Giuntini F, Eggleston I, Furutani-Seiki M, Ishima R et al. Structural features and ligand binding properties of tandem WW domains from YAP and TAZ, nuclear effectors of the Hippo pathway. Biochemistry 2011; 50: 3300-3309
16. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 2010; 24: 72-85
17. Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D et al. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem 2010; 285: 37159-37169
18. Burglin TR. The TEA domain: A novel, highly conserved DNA-binding motif. Cell 1991; 66: 11-12
19. Sudol M, Harvey KF. Modularity in the Hippo signaling pathway. Trends Biochem Sci 2010; 35: 627-633
20. Van Hateren NJ, Das RM, Hautbergue GM, Borycki AG, Placzek M, Wilson SA. FatJ acts via the Hippo mediator Yap1 to restrict the size of neural progenitor cell pools. Development 2011; 138: 1893-1902
21. Mao Y, Mulvaney J, Zakaria S, Yu T, Morgan KM, Allen S et al. Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian Development. Development 2011; 138: 947-957
22. Saburi S, Hester I, Fischer E, Pontoglio M, Eremina V, Gessler M et al. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat Genet 2008; 40: 1010-1015
23. Lawrence PA, Struhl G, Casal J. Do the protocadherins Fat and Dachsous link up to determine both planar cell polarity and the dimensions of organs?. Nat Cell Biol 2008; 10: 1379-1382
24. Reddy BV, Irvine KD. The Fat and Warts signaling pathways: New insights into their regulation, mechanism and conservation. Development 2008; 135: 2827-2838
25. Sopko R, McNeill H. The skinny on Fat: An enormous cadherin that regulates cell adhesion, tissue growth, and planar cell polarity. Curr Opin Cell Biol 2009; 21: 717-723
26. Visser-Grieve S, Hao Y, Yang X. Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway. Oncogene 2011; 31: 1189-1195
27. Angus L, Moleirinho S, Herron L, Sinha A, Zhang X, Niestrata M et al. Willin/ FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. Oncogene 2011; 31: 238-250
28. Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol 2006; 16: 2101-2110
29. Cho E, Feng Y, Rauskolb C, Maitra S, Fehon R, Irvine KD. Delineation of a Fat tumor suppressor pathway. Nat Genet 2006; 38: 1142-1150
30. Silva E, Tsatskis Y, Gardano L, Tapon N, McNeill H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr Biol 2006; 16: 2081-2089
31. Tyler DM, Baker NE. Expanded and fat regulate growth and differentiation in the Drosophila eye through multiple signaling pathways. Dev Biol 2007; 305: 187-201
32. Willecke M, Hamaratoglu F, Kango-Singh M, Udan R, Chen CL, Tao C et al. The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr Biol 2006; 16: 2090-2100
33. Castillejo-Lopez C, Arias WM, Baumgartner S. The fat-like gene of Drosophila is the true orthologue of vertebrate fat cadherins and is involved in the formation of tubular organs. J Biol Chem 2004; 279: 24034-24043
34. Viktorinova I, Konig T, Schlichting K, Dahmann C. The cadherin Fat2 is required for planar cell polarity in the Drosophila ovary. Development 2009; 136: 4123-4132
35. Avruch J, Zhou D, Fitamant J, Bardeesy N. Mst1/2 signalling to Yap: Gatekeeper for liver size and tumour development. Br J Cancer 2011; 104: 24-32
36. Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010; 19: 27-38
37. Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M et al. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev 2010; 24: 1718-1730
38. Cho E, Irvine KD. Action of fat, four-jointed, dachsous and dachs in Distal-toproximal wing signaling. Development 2004; 131: 4489-4500
39. Rogulja D, Rauskolb C, Irvine KD. Morphogen control of wing growth through the Fat signaling pathway. Dev Cell 2008; 15: 309-321
40. Mao Y, Rauskolb C, Cho E, Hu WL, Hayter H, Minihan G et al. Dachs: An unconventional myosin that functions downstream of Fat to regulate growth, affinity and gene expression in Drosophila. Development 2006; 133: 2539-2551
41. Brittle A, Thomas C, Strutt D. Planar polarity specification through asymmetric subcellular localization of Fat and Dachsous. Curr Biol 2012; 22: 907-914
42. Matakatsu H, Blair SS. The DHHC palmitoyltransferase approximated regulates fat signaling and Dachs localization and activity. Curr Biol 2008; 18: 1390-1395
43. Ambegaonkar AA, Pan G, Mani M, Feng Y, Irvine KD. Propagation of Dachsous fat planar cell polarity. Curr Biol 2012; 22: 1302-1308
44. Mao Y, Tournier AL, Bates PA, Gale JE, Tapon N, Thompson BJ. Planar polarization of the atypical myosin Dachs orients cell divisions in Drosophila. Genes Dev 2011; 25: 131-136
45. Matakatsu H, Blair SS. Separating the adhesive and signaling functions of the Fat and Dachsous protocadherins. Development 2006; 133: 2315-2324
46. Bischof J, Maeda RK, Hediger M, Karch F, Basler K. An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci USA 2007; 104: 3312-3317
47. Matakatsu H, Blair SS. Separating planar cell polarity and Hippo pathway activities of the protocadherins Fat and Dachsous. Development 2012; 139: 1498-1508
48. Weber KL, Sokac AM, Berg JS, Cheney RE, Bement WM. A microtubule-binding myosin required for nuclear anchoring and spindle assembly. Nature 2004; 431: 325-329
49. Zhang H, Berg JS, Li Z, Wang Y, Lang P, Sousa AD et al. Myosin-X provides a motor-based link between integrins and the cytoskeleton. Nat Cell Biol 2004; 6: 523-531
50. Bulgakova NA, Knust E. The Crumbs complex: From epithelial-cell polarity to retinal degeneration. J Cell Sci 2009; 122(Part 15): 2587-2596
51. Oka T, Schmitt AP, Sudol M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP. Oncogene 2011; 31: 128-134
52. Chan SW, Lim CJ, Chong YF, Pobbati AV, Huang C, Hong W. Hippo pathwayindependent restriction of TAZ and YAP by angiomotin. J Biol Chem 2011; 286: 7018-7026
53. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 2011; 25: 51-63
54. Wang W, Huang J, Chen J. Angiomotin-like proteins associate with and negatively regulate YAP1. J Biol Chem 2011; 286: 4364-4370
55. Ernkvist M, Aase K, Ukomadu C, Wohlschlegel J, Blackman R, Veitonmaki N et al. P130-angiomotin associates to actin and controls endothelial cell shape. FEBS J 2006; 273: 2000-2011
56. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 2010; 19: 831-844
57. Chen HI, Einbond A, Kwak SJ, Linn H, Koepf E, Peterson S et al. Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands. J Biol Chem 1997; 272: 17070-17077
58. Kay BK, Williamson MP, Sudol M. The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 2000; 14: 231-241
59. Oka T, Remue E, Meerschaert K, Vanloo B, Boucherie C, Gfeller D et al. Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling. Biochem J 2010; 432: 461-472
60. Oka T, Sudol M. Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells 2009; 14: 607-615
61. Chen CL, Gajewski KM, Hamaratoglu F, Bossuyt W, Sansores-Garcia L, Tao C et al. The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc Natl Acad Sci USA 2010; 107: 15810-15815
62. Ling C, Zheng Y, Yin F, Yu J, Huang J, Hong Y et al. The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc Natl Acad Sci USA 2010; 107: 10532-10537
63. Robinson BS, Huang J, Hong Y, Moberg KH. Crumbs regulates Salvador/Warts/ Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr Biol 2010; 20: 582-590
64. Yu J, Zheng Y, Dong J, Klusza S, Deng W-M, Pan D. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Develop Cell 2010; 18: 288-299
65. Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C et al. The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 2006; 8: 27-36
66. Oh H, Reddy BV, Irvine KD. Phosphorylation-independent repression of Yorkie in Fat-Hippo signaling. Dev Biol 2009; 335: 188-197
67. Badouel C, Gardano L, Amin N, Garg A, Rosenfeld R, Le Bihan T et al. The FERMdomain protein Expanded regulates Hippo pathway activity via direct interactions with the transcriptional activator Yorkie. Dev Cell 2009; 16: 411-420
68. Grzeschik NA, Parsons LM, Allott ML, Harvey KF, Richardson HE. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr Biol 2010; 20: 573-581
69. Parsons LM, Grzeschik NA, Allott ML, Richardson HE. Lgl/aPKC and Crb regulate the Salvador/Warts/Hippo pathway. Fly (Austin) 2010; 4: 288-293
70. Pellock BJ, Buff E, White K, Hariharan IK. The Drosophila tumor suppressors Expanded and Merlin Differentially regulate cell cycle exit, apoptosis, and Wingless signaling. Dev Biol 2007; 304: 102-115
71. Boedigheimer MJ, Nguyen KP, Bryant PJ. Expanded functions in the apical cell domain to regulate the growth rate of imaginal discs. Dev Genet 1997; 20: 103-110
72. Jaramillo BE, Ponce A, Moreno J, Betanzos A, Huerta M, Lopez-Bayghen E et al. Characterization of the tight junction protein ZO-2 localized at the nucleus of epithelial cells. Exp Cell Res 2004; 297: 247-258
73. Remue E, Meerschaert K, Oka T, Boucherie C, Vandekerckhove J, Sudol M et al. TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner. FEBS Lett 2010; 584: 4175-4180
74. Leys SP, Riesgo A. Epithelia, an evolutionary novelty of metazoans. J Exp Zool Part B 2012; 318: 438-447
75. Yue T, Tian A, Jiang J. The cell adhesion molecule echinoid functions as a tumor suppressor and upstream regulator of the Hippo signaling pathway. Develop Cell 2012; 22: 255-267
76. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 2012; 150: 780-791
77. Enomoto M, Igaki T. Src controls tumorigenesis via JNK-dependent regulation of the Hippo pathway in Drosophila. EMBO Rep 2013; 14: 65-72
78. Boggiano JC, Fehon RG. Growth control by committee: Intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell 2012; 22: 695-702
79. Bosveld F, Bonnet I, Guirao B, Tlili S, Wang Z, Petitalot A et al. Mechanical control of morphogenesis by Fat/Dachsous/Four-jointed planar cell polarity pathway. Science 2012; 336: 724-727
80. Liu KC, Jacobs DT, Dunn BD, Fanning AS, Cheney RE. Myosin-X functions in polarized epithelial cells. Mol Biol Cell 2012; 23: 1675-1687
81. Toyoshima F, Nishida E. Integrin-mediated adhesion orients the spindle parallel to the substratum in an EB1- and myosin X-dependent manner. EMBO J 2007; 26: 1487-1498
82. Kim NG, Koh E, Chen X, Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA 2011; 108: 11930-11935
83. Ishiuchi T, Misaki K, Yonemura S, Takeichi M, Tanoue T. Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex. J Cell Biol 2009; 185: 959-967
84. Mauviel A, Nallet-Staub F, Varelas X. Integrating developmental signals: A Hippo in the (path) way. Oncogene 2011; 31: 1743-1756
85. Polesello C, Tapon N. Salvador-warts-hippo signaling promotes Drosophila posterior follicle cell maturation Downstream of notch. Curr Biol 2007; 17: 1864-1870
86. Bu X, Avraham HK, Li X, Lim B, Jiang S, Fu Y et al. Mayven induces c-Jun expression and cyclin D1 activation in breast cancer cells. Oncogene 2005; 24: 2398-2409
87. MacDougall N, Lad Y, Wilkie GS, Francis-Lang H, Sullivan W, Davis I. Merlin, the Drosophila homologue of neurofibromatosis-2, is specifically required in posterior follicle cells for axis formation in the oocyte. Development 2001; 128: 665-673
88. Milton CC, Zhang X, Albanese NO, Harvey KF. Differential requirement of Salvador-Warts-Hippo pathway members for organ size control in Drosophila melanogaster. Development 2010; 137: 735-743
89. Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD et al. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Science Signal 2011; 4ra33
90. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011; 144: 782-795
91. Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 2010; 18: 309-316
92. Boedigheimer M, Laughon A. Expanded: A gene involved in the control of cell proliferation in imaginal discs. Development 1993; 118: 1291-1301
93. Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 2010; 18: 300-308
94. McCartney BM, Kulikauskas RM, LaJeunesse DR, Fehon RG. The Neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 2000; 127: 1315-1324
95. Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 2010; 18: 288-299
96. Langer EM, Feng Y, Zhaoyuan H, Rauscher III FJ, Kroll KL, Longmore GD et al. Proteins are snail/slug corepressors required for neural crest development in Xenopus. Dev Cell 2008; 14: 424-436
97. Marie H, Pratt SJ, Betson M, Epple H, Kittler JT, Meek L et al. The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin. J Biol Chem 2003; 278: 1220-1228
98. Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE. Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene 2008; 27: 6888-6907
99. Grzeschik NA, Parsons LM, HE Richardson. Lgl, the SWH pathway and tumorigenesis: It's a matter of context & competition! Cell Cycle 2010; 9: 3202-3212
100. Ziosi M, Baena-Lopez LA, Grifoni D, Froldi F, Pession A, Garoia F et al. dMyc functions downstream of Yorkie to promote the supercompetitive behavior of hippo pathway mutant cells. PLoS Genet 2010; 6: E1001140
101. Menendez J, Perez-Garijo A, Calleja M, Morata G. A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway. Proc Natl Acad Sci USA 2010; 107: 14651-14656
102. Muller HA, Bossinger O. Molecular networks controlling epithelial cell polarity in Development. Mech Dev 2003; 120: 1231-1256
103. Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Bellen HJ et al. Sharpei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 2002; 129: 5719-5730
104. Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 2012; 26: 1300-1305